Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "COVID"

1142 News Found

MicroGEM granted EUA for Covid-19 PCR Saliva test
Biotech | April 20, 2022

MicroGEM granted EUA for Covid-19 PCR Saliva test

The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes


WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19
News | April 19, 2022

WHO report highlights the role of traditional Chinese medicine in the treatment of Covid-19

The report pointed out that in the process of treating Covid-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe Covid-19


Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan
Drug Approval | April 19, 2022

Takeda announces approval of Nuvaxovid Covid-19 vaccine in Japan

Approval for primary and booster immunization is based on efficacy and safety data from Japan and international clinical studies


Albumedix and Valneva expand collaboration to include newly approved inactivated Covid-19 vaccine
Biotech | April 18, 2022

Albumedix and Valneva expand collaboration to include newly approved inactivated Covid-19 vaccine

This marks an expansion of the companies' existing collaboration and further validates the use of Albumedix Recombumin rHA products in the manufacturing process and final formulation of critical vaccines


Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine
Biotech | April 13, 2022

Switzerland grants conditional marketing authorisation for Novavax Covid-19 vaccine

Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland


USFDA grants direct RMAT designation for the use of ExoFlo in Covid-19 related ARDS
Biotech | April 13, 2022

USFDA grants direct RMAT designation for the use of ExoFlo in Covid-19 related ARDS

An RMAT confers eligibility for accelerated approval and priority review of biologics licensing applications (BLA)


Novel Covid-19 vaccine may protect the immunocompromised
Biotech | April 13, 2022

Novel Covid-19 vaccine may protect the immunocompromised

The peptide-based vaccine induces a t cell-dependent response


CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid
Biotech | April 11, 2022

CUHK researchers discover distinct gut microbial signatures for prediction, diagnosis and treatment of long Covid

These distinct gut microbial signatures can be used to predict the risk of developing long Covid and diagnose long Covid in patients with persistent symptoms after the acute infection


Data indicates homeopathy effective in management of long Covid
News | April 10, 2022

Data indicates homeopathy effective in management of long Covid

Dr. Kalyan Banerjee's Clinic developed a homeopathy prophylaxis protocol for the prevention of Covid-19 as soon as the pandemic began


Proof Diagnostics seeks EUA for CRISPR-based molecular point-of-care Covid-19 test
Biotech | April 08, 2022

Proof Diagnostics seeks EUA for CRISPR-based molecular point-of-care Covid-19 test

If authorized by the USFDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for Covid-19 in as little as 18 minutes